Clinical Trial: Cryoablation+Ipilimumab+Nivolumab in Melanoma
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Metastatic Melanoma
Study Type: INTERVENTIONAL
Official Title: A Phase II Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Advanced Melanoma Receiving Post-progression Dual Immune Checkpoint Inhibitor Therapy
Brief Summary:
The aim of this study is to find out whether the combination of two approved drugs, ipilimumab and nivolumab, in combination with cryoablation are safe and effective for participants who have an unresectable melanoma that is resistant, or is growing, after receiving immunotherapy with a PD-1 inhibitor.The names of the study interventions involved in this study are:Cryoablation (an interventional radiology procedure that freezes part of a tumor)Ipilimumab (an immunotherapy)Nivolumab (an immunotherapy)
Read more